Binx IO Instrument PCA This non-invasive test detects SARS-CoV-2

This non-invasive test detects SARS-CoV-2 nucleocapsid protein antigen from a direct anterior nasal and nasopharyngeal swab specimen

This advanced formulation has been scientifically designed by a team of medical professionals to ensure the highest potency and purity for optimal therapeutic benefits

EMERGENCY USE AUTHORIZATION (EUA) LETTER

Fingers textured

and healthy cholesterol & triglyceride levels

Binx IO Instrument PCA This non-invasive test detects SARS-CoV-2The FDA cleared, CLIA waived, rapid molecular POC platform offering Chlamydia and Gonorrhea PCR testing. Easy to use platform requires no calibration, preventative maintenance, or interpretation of results and can be used by non lab trained personnel.* Easy to install and use.* Fully automated.* Requires no calibration, preventative maintenance* FDA cleared and CLIA waived* For Point of Care molecular PCR testing* Results available in under 30